http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24571b40f2ed356c257a0c0a170babd5
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Dixon Michael Dixon |
| name | J Michael Dixon J. Michael Dixon |
| given-name | J. J. Michael J Michael |
| organization-name | 4Edinburgh Breast Unit, Edinburgh; From the Breast Research Group, University of Edinburgh, Edinburgh, United Kingdom; Genomics Institute of the Novartis Research Foundation, San Diego, CA; and Novartis Pharma AG, Basel, Switzerland. Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland. Western General Hospital, Edinburgh, UK. From the Edinburgh Breast Unit and Department of Oncology, Western General Hospital, Edinburgh; Academic Department of Biochemistry, Royal Marsden Hospital, London; and the Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom Edinburgh Breast Unit, Western General Hospital Authors' Affiliations: 1Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, 2Department of Biochemistry and Molecular Biology, 3Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and 4Department of Oncology, Mayo Clinic, Rochester, Minnesota; 5Breast Unit, Department of Clinical Oncology, Western General Hospital, University of Edinburgh; 6Breakthrough Research Unit, Edinburgh, United Kingdom; and 7M.D. Anderson Cancer Center Oncology, Houston, Texas; Authors' Affiliations: 1Division of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, 2Department of Biochemistry and Molecular Biology, 3Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, and 4Department of Oncology, Mayo Clinic, Rochester, Minnesota; 5Breast Unit, Department of Clinical Oncology, Western General Hospital, University of Edinburgh; 6Breakthrough Research Unit, Edinburgh, United Kingdom; and 7M.D. Anderson Cancer Center Oncology, Houston, Texas From the Siteman Comprehensive Cancer Center, Washington University School of Medicine, St Louis, MO; Duke University Medical Center, Durham, NC; Edinburgh Breast Unit, Edinburgh University, Edinburgh, Scotland; Royal Marsden Hospital, London, United Kingdom; and Novartis Pharma AG, Basel, Switzerland. Breakthrough Breast Cancer Research Unit and; Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom Edinburgh Breast Unit, Western General Hospital, Edinburgh, EH4 2XU, UK Consultant Surgeon & Senior Lecturer in Surgery, Clinical Director, Breakthrough Research Unit, Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, UK, Tel.: +44 131 537 2907; Fax: +44 131 537 2653; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand. From the Vall d'Hebron University Hospital, Barcelona; Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain; NN Petrov Research Institute of Oncology; and City Oncological Dispensary, St Petersburg, Russian Federation; Onc Centrum St Augustinus, Wilrijk, Belgium; Centre Rene Gauducheau, Nantes, France; Department of Special Gynecology, Medical University of Vienna/Austria; University Hospital, Salzburg, Austria; Istituto Nazionale Tumori, Milan, Italy; Novartis Pharma AG, Basel, Switzerland;... From the Screening and Test Evaluation Program, School of Public Health, Faculty of Medicine, and National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia; Breakthrough Research Unit, Edinburgh, Scotland; Department of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom; and Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy. Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland, UK. Breakthrough Breast Cancer Research Unit, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom. Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom Breakthrough Research Unit, Edinburgh, Edinburgh Breast Unit,Western General Hospital, Edinburgh EH4 2XU University Department of Surgery The Royal Infirmary EH3 9YW Edinburgh England UK 7Western General Hospital, Edinburgh, United Kingdom. Breast Cancer Now Edinburgh Team, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK; Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK From the Academic Department of Biochemistry and the Breast Unit, Royal Marsden Hospital, London; Mayday University Hospital, Croydon, Surrey; Edinburgh Breast Unit, Edinburgh; Royal Bournemouth Hospital, Bournemouth, Dorset; Royal Victoria Infirmary, Newcastle Upon Tyne, Tyne and Wear; and AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom Breakthrough Research Unit, Edinburgh, Edinburgh Breast Unit, Wes tern General Hospital, Edinburgh, EH4 2XU, UK Edinburgh Breast UnitEdinburghScotland 4Edinburgh Breast Unit Western General Hospital, Edinburgh, United Kingdom.; 5Edinburgh Cancer Research Center, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. 5University of Edinburgh Cancer, Research UK Centre, Edinburgh. Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, UK. jmd@wght.demon.co.uk From the University of Edinburgh (I.H.K., L.J.W., D.A.C., J.M.D.) and Western General Hospital (W.J.L.J.) — both in Edinburgh. 4Edinburgh Breast Unit, Edinburgh, United Kingdom; Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU Authors' Affiliations: 1Department of Academic Surgery, University Hospital of South Manchester, 2Breakthrough Breast Cancer Research, Christie Hospital, and 3Department of Medical Statistics, University Hospital of South Manchester, Manchester United Kingdom; 4Edinburgh Breast Unit, Edinburgh, United Kingdom; and 5Department of Breast Surgery, University of Nottingham, Nottingham University Hospitals, United Kingdom Edinburgh Breast Unit, Western General Hospital Edinburgh, UK From the Screening and Test Evaluation Program, School of Public Health; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia; Department of Diagnostic Imaging, Centro per lo Studio e la Prevenzione Oncologica, Istituto Scientifico della Regione Toscana, Florence, Italy; Department of Radiology, Addenbrooke's Hospital, Cambridge, United Kingdom; and the Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland Western General Hospital, Edinburgh EH4 2XU, United Kingdom; Elizabeth J. Folkerd and Mitch Dowsett, Royal Marsden Hospital, London; J. Michael Dixon and Lorna Renshaw, Western General Hospital, Edinburgh; and Roger P. A'Hern, Institute for Cancer Research, Sutton, United Kingdom. Edinburgh Breast Unit Western General Hospital Edinburgh UK Edinburgh Breast Unit, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom. Breast Cancer Now Edinburgh Research Team, MRC Institute of Genetics & Molecular Medicine, Western General Hospital, University of Edinburgh, Edinburgh, EH4 2XU, UK; Edinburgh Breast Unit, Western General Hospital, NHS Lothian, Edinburgh, EH4 2XU, UK Breakthrough Breast Cancer Research Unit; Edinburgh University, Western General Hospital; Edinburgh United Kingdom 5Western General Hospital, Edinburgh, Scotland; Breakthrough Research Unit, Edinburgh, Scotland, United Kingdom Breakthrough Research Unit Edinburgh Breast Unit Western General Hospital Edinburgh United Kingdom 9Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom. Edinburgh Breast Unit, Western General Hospital, NHS Lothian, Edinburgh Eh4 2XU, UK Translational Oncology Research Group, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland; Edinburgh Breast Cancer Now Research Team, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland; Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland University of Edinburgh, Western General Hospital, Scotland, United Kingdom. |
Incoming Links
Total number of triples: 208.